stock
UroGen Pharma Ltd
NASDAQ | URGN
17.32
USD
$0.00
(0.00%
)At Close (As of Oct 23, 2025)
$817.03M
Market Cap
-
P/E Ratio
-3.06
EPS
$21.71
52 Week High
$3.42
52 Week Low
HEALTHCARE
Sector
URGN Chart
Recent Chart
Price Action
URGN Technicals
URGN Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $82M |
| Total Revenue | $90M |
| Cost Of Revenue | $8.9M |
| Costof Goods And Services Sold | $8.9M |
| Operating Income | -$97M |
| Selling General And Administrative | $121M |
| Research And Development | $57M |
| Operating Expenses | $178M |
| Investment Income Net | - |
| Net Interest Income | -$3.6M |
| Interest Income | $8.9M |
| Interest Expense | $13M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.2M |
| Income Before Tax | -$124M |
| Income Tax Expense | $2.8M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$127M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$112M |
| Ebitda | -$110M |
| Net Income | -$127M |
Revenue & Profitability
Earnings Performance
URGN Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $286M |
| Total Current Assets | $276M |
| Cash And Cash Equivalents At Carrying Value | $172M |
| Cash And Short Term Investments | $172M |
| Inventory | $9.2M |
| Current Net Receivables | $20M |
| Total Non Current Assets | $9.6M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | $5M |
| Short Term Investments | $65M |
| Other Current Assets | $9.9M |
| Other Non Current Assets | - |
| Total Liabilities | $295M |
| Total Current Liabilities | $46M |
| Current Accounts Payable | $11M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $3.1M |
| Total Non Current Liabilities | $249M |
| Capital Lease Obligations | $1.7M |
| Long Term Debt | $122M |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $123M |
| Other Current Liabilities | $27M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | -$8.8M |
| Treasury Stock | - |
| Retained Earnings | -$806M |
| Common Stock | $115K |
| Common Stock Shares Outstanding | $43M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$97M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $1.2M |
| Capital Expenditures | $295K |
| Change In Receivables | - |
| Change In Inventory | -$3.6M |
| Profit Loss | - |
| Cashflow From Investment | -$21M |
| Cashflow From Financing | $195M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$127M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $82M |
| Total Revenue | $90M |
| Cost Of Revenue | $8.9M |
| Costof Goods And Services Sold | $8.9M |
| Operating Income | -$97M |
| Selling General And Administrative | $121M |
| Research And Development | $57M |
| Operating Expenses | $178M |
| Investment Income Net | - |
| Net Interest Income | -$3.6M |
| Interest Income | $8.9M |
| Interest Expense | $13M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $1.2M |
| Income Before Tax | -$124M |
| Income Tax Expense | $2.8M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$127M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$112M |
| Ebitda | -$110M |
| Net Income | -$127M |
URGN News
URGN Profile
UroGen Pharma Ltd Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None
YYAI -50.60%
$0.09
BYND -20.67%
$2.84
SCNX +354.94%
$2.60
YDKG
+5.58%
$0.07
F -0.72%
$12.34
CGBS -39.47%
$0.03
VHAI 0.00%
$0.00
RGTI +9.80%
$39.59
AIRE +38.18%
$0.98
RIG +13.74%
$3.89
TSLA +2.28%
$448.98
INTC +3.35%
$38.15
BURU
-5.27%
$0.34
VTYX +70.98%
$6.60
NOK +11.17%
$6.17
QBTS +13.81%
$31.06
NVDA +1.04%
$182.16
T -3.63%
$24.62
ADAP -3.44%
$0.07
MSAI +101.73%
$1.35
AAL +5.62%
$12.77
BITF +5.71%
$4.16
VIVK +5.68%
$0.26
WTO -7.04%
$0.06
IONZ
-14.59%
$3.98
AREB +75.34%
$3.77
AXDX -61.36%
$0.03
DNN +0.36%
$2.73
IONQ +7.06%
$59.37
PLUG -1.36%
$2.88
ABEV +0.45%
$2.21
SMCI -8.72%
$47.92
QUBT +7.19%
$15.94
TLRY +2.06%
$1.48
VZ -3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB +1.77%
$5.72
SOFI +3.27%
$28.08
RBNE
+7.87%
$1.37
BBD +1.51%
$3.35
JOBY +1.29%
$15.67
RF -0.04%
$24.10
WGRX +9.03%
$0.40
CAN +3.22%
$1.76
ETHD -3.17%
$3.97
ACHR +0.46%
$10.91
QS +7.95%
$14.66
SGBX +29.82%
$2.96
RMBL +60.50%
$3.21
AMD +2.06%
$234.99
BTG +0.38%
$5.23
ADD -25.47%
$0.05
VLY +4.24%
$10.56
ONDS +4.74%
$7.06
GPUS
-0.28%
$0.38
PLTR +2.84%
$180.48
LAES +5.92%
$5.72
RXRX -0.34%
$5.73
SRM +53.27%
$10.30
CIFR +7.10%
$17.25
PFE -0.20%
$24.67
TNGX -13.04%
$7.53
UUUU -6.50%
$21.26
BTBT +3.62%
$3.72
AAPL +0.43%
$259.58
MARA +0.36%
$19.22
AMC -0.72%
$2.73
DVLT +5.14%
$2.25
WBD +3.50%
$21.25
AMZN +1.44%
$221.09
IREN +7.77%
$55.86
HPE +0.43%
$23.19
PBR +0.93%
$11.84
NIO +0.73%
$6.89
IBIO -8.63%
$1.27
CUTR -10.19%
$0.09
KMI -4.75%
$26.25
NVTS +0.03%
$13.61
WLGS -5.57%
$0.04
SOUN +2.70%
$18.23
SCWO +32.07%
$0.48
LUV -6.25%
$31.65
RR +7.11%
$5.42
TE -9.73%
$3.71
ETWO 0.00%
$3.30
SNAP +1.28%
$7.87
BAC +1.29%
$51.76
RIVN +1.31%
$13.09
BTE +5.72%
$2.40
APLD +9.01%
$33.38
VALE -0.52%
$11.46
HOOD +5.58%
$134.33
DNUT +1.98%
$4.11
LUMN +10.65%
$7.79
AFMD -34.94%
$0.18
NCLH -0.63%
$23.48
ERIC -0.31%
$9.48
CLSK +4.80%
$17.67
KDLY +10.41%
$0.79
NAKA
+10.41%
$0.79
YYAI -50.60%
$0.09
BYND -20.67%
$2.84
SCNX +354.94%
$2.60
YDKG
+5.58%
$0.07
F -0.72%
$12.34
CGBS -39.47%
$0.03
VHAI 0.00%
$0.00
RGTI +9.80%
$39.59
AIRE +38.18%
$0.98
RIG +13.74%
$3.89
TSLA +2.28%
$448.98
INTC +3.35%
$38.15
BURU
-5.27%
$0.34
VTYX +70.98%
$6.60
NOK +11.17%
$6.17
QBTS +13.81%
$31.06
NVDA +1.04%
$182.16
T -3.63%
$24.62
ADAP -3.44%
$0.07
MSAI +101.73%
$1.35
AAL +5.62%
$12.77
BITF +5.71%
$4.16
VIVK +5.68%
$0.26
WTO -7.04%
$0.06
IONZ
-14.59%
$3.98
AREB +75.34%
$3.77
AXDX -61.36%
$0.03
DNN +0.36%
$2.73
IONQ +7.06%
$59.37
PLUG -1.36%
$2.88
ABEV +0.45%
$2.21
SMCI -8.72%
$47.92
QUBT +7.19%
$15.94
TLRY +2.06%
$1.48
VZ -3.51%
$38.40
RGTZ
-20.27%
$14.90
GRAB +1.77%
$5.72
SOFI +3.27%
$28.08
RBNE
+7.87%
$1.37
BBD +1.51%
$3.35
JOBY +1.29%
$15.67
RF -0.04%
$24.10
WGRX +9.03%
$0.40
CAN +3.22%
$1.76
ETHD -3.17%
$3.97
ACHR +0.46%
$10.91
QS +7.95%
$14.66
SGBX +29.82%
$2.96
RMBL +60.50%
$3.21
AMD +2.06%
$234.99
BTG +0.38%
$5.23
ADD -25.47%
$0.05
VLY +4.24%
$10.56
ONDS +4.74%
$7.06
GPUS
-0.28%
$0.38
PLTR +2.84%
$180.48
LAES +5.92%
$5.72
RXRX -0.34%
$5.73
SRM +53.27%
$10.30
CIFR +7.10%
$17.25
PFE -0.20%
$24.67
TNGX -13.04%
$7.53
UUUU -6.50%
$21.26
BTBT +3.62%
$3.72
AAPL +0.43%
$259.58
MARA +0.36%
$19.22
AMC -0.72%
$2.73
DVLT +5.14%
$2.25
WBD +3.50%
$21.25
AMZN +1.44%
$221.09
IREN +7.77%
$55.86
HPE +0.43%
$23.19
PBR +0.93%
$11.84
NIO +0.73%
$6.89
IBIO -8.63%
$1.27
CUTR -10.19%
$0.09
KMI -4.75%
$26.25
NVTS +0.03%
$13.61
WLGS -5.57%
$0.04
SOUN +2.70%
$18.23
SCWO +32.07%
$0.48
LUV -6.25%
$31.65
RR +7.11%
$5.42
TE -9.73%
$3.71
ETWO 0.00%
$3.30
SNAP +1.28%
$7.87
BAC +1.29%
$51.76
RIVN +1.31%
$13.09
BTE +5.72%
$2.40
APLD +9.01%
$33.38
VALE -0.52%
$11.46
HOOD +5.58%
$134.33
DNUT +1.98%
$4.11
LUMN +10.65%
$7.79
AFMD -34.94%
$0.18
NCLH -0.63%
$23.48
ERIC -0.31%
$9.48
CLSK +4.80%
$17.67
KDLY +10.41%
$0.79
NAKA
+10.41%
$0.79